ORIGINAL RESEARCH
Accepted on 25 Aug 2025
CXCR4 Antagonism Corrects Neutrophil Abnormalities and Reduces Pneumonia Severity in a Pharmacological Mouse Model of CXCR2 Loss-of-Function-Mediated Neutropenia
doi 10.3389/fimmu.2025.1658987
- 895 views
- Frontiers in Immunology
- Primary Immunodeficiencies
- Research Topics
- Advancing Research, Clinical Recognition, and Targeted Therapies for WHIM Syndrome
Advancing Research, Clinical Recognition, and Targeted Therapies for WHIM Syndrome
3,047
Total downloads
13k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 20 Aug 2025
Case Report: A novel CXCR4 variant (p.S341Y) in a family with a pathogenic NFKB1 variant and variable clinical manifestations
doi 10.3389/fimmu.2025.1641122
- 890 views
ORIGINAL RESEARCH
Published on 11 Nov 2024
CXCR4 antagonism ameliorates leukocyte abnormalities in a preclinical model of WHIM syndrome
doi 10.3389/fimmu.2024.1468823
- 1,799 views
- 1 citation
ORIGINAL RESEARCH
Published on 07 Nov 2024
Heterogeneous phenotype of a Chinese Familial WHIM syndrome with CXCR4V340fs gain-of-function mutation
doi 10.3389/fimmu.2024.1460990
- 1,221 views
MINI REVIEW
Published on 08 Jul 2024
Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation
doi 10.3389/fimmu.2024.1411141
- 2,777 views
- 2 citations
REVIEW
Published on 05 Jul 2024
The complex nature of CXCR4 mutations in WHIM syndrome
doi 10.3389/fimmu.2024.1406532
- 2,870 views
- 3 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.